Evidence map›Paper›PMID 35110545›Full record

ArticleCell death & disease2022

Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation.

Minle Li, Xue Zhao, Hongmei Yong, Jian Xu, Pengfei Qu, Shuxi Qiao, Pingfu Hou, Zhongwei Li, Sufang Chu, Junnian Zheng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Identification of telomere-related diagnostic markers in osteoarthritis based on bioinformatics analysis and machine learning.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Minle Li *Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Xue Zhao *Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Hongmei Yong *Department of Oncology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The second People's Hospital of Huai'an, Huai'an, 223002, China.
Jian XuCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Pengfei QuCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Shuxi QiaoCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Pingfu HouCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Zhongwei LiCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Sufang ChuCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Junnian ZhengCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. jnzheng@xzhmu.edu.cn.ORCID 0000-0003-0208-6410
Jin BaiCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. bj@xzhmu.edu.cn.ORCID 0000-0003-1524-7893
Xuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transketolase (TKT) which is an important metabolic enzyme in the pentose phosphate pathway (PPP) participates in maintaining ribose 5-phosphate levels. TKT is necessary for maintaining cell growth. However, we found that in addition to this, TKT can also affect tumor progression through other ways. Our previous study indicate that TKT could promote the development of liver cancer by affecting bile acid metabolism. And in this study, we discovered that TKT expression was remarkably upregulated in colorectal cancer, abnormal high expression of TKT is associated with poor prognosis of colorectal cancer. Additionally, TKT promoted colorectal cancer cell growth and metastasis. Further study demonstrated that TKT interacted with GRP78 and promoted colorectal cancer cell glycolysis through increasing AKT phosphorylation, thereby enhancing colorectal cancer cell metastasis. Thus, TKT is expected to become an indicator for judging the prognosis of colorectal cancer, and provide a theoretical basis for drug development of new treatment targets for colorectal cancer.

Indexed as

Cell Line, TumorCell ProliferationColorectal NeoplasmsEndoplasmic Reticulum Chaperone BiPFemaleGlycolysisHumansMaleMiddle AgedNeoplasm MetastasisPhosphorylationPrognosisProtein BindingProto-Oncogene Proteins c-aktTransketolaseEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanProto-Oncogene Proteins c-aktTransketolase

Identifiers

PMID35110545
PMCPMC8810869
OpenAlexW4210444659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.